Research graph
References from Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction. Local targets link to admitted publications; unresolved targets remain external evidence.
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
10.1016/j.jacc.2013.05.019 · 2013 · External reference
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
10.1016/j.jacc.2014.08.036 · 2014 · External reference
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation
10.1016/j.jacc.2013.02.092 · 2013 · External reference
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure
10.1161/circheartfailure.110.958199 · 2011 · External reference
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction
10.1161/circheartfailure.109.931451 · 2011 · External reference
Myocardial structure and function differ in systolic and diastolic heart failure
10.1161/circulationaha.105.587519 · 2006 · External reference
Hypertrophy of the heart: a new therapeutic target?
10.1161/01.cir.0000120390.68287.bb · 2004 · External reference
Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP). Cloning and sequence of the human homologue
10.1111/j.1432-1033.1994.0937b.x · 1994 · External reference
Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines
10.1016/s0304-3835(00)00407-9 · 2000 · External reference
Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis
10.1002/art.20023 · 2004 · External reference
Follistatin-like protein-1 is a novel proinflammatory molecule
10.4049/jimmunol.177.7.4758 · 2006 · External reference
Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart
10.1161/circulationaha.108.767673 · 2008 · External reference
Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism
10.1074/jbc.m803440200 · 2008 · External reference
Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling
10.1161/circheartfailure.110.960625 · 2011 · External reference
Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure
10.1161/hypertensionaha.109.134932 · 2009 · External reference
Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction
10.1161/circheartfailure.114.001279 · 2014 · External reference
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure
10.1210/en.2009-0806 · 2010 · External reference
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
10.1073/pnas.1108559108 · 2011 · External reference
Developmental changes in left and right ventricular diastolic filling patterns in mice
10.1152/ajpheart.00384.2003 · 2003 · External reference
Assessment of left ventricular mass in mice: comparison between two-dimensional and m-mode echocardiography
10.1046/j.1540-8175.2002.00199.x · 2002 · External reference
Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment
10.1016/j.cardiores.2007.02.010 · 2007 · External reference
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling
10.1152/ajpheart.00428.2011 · 2011 · External reference
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings
10.1016/0002-9149(86)90771-x · 1986 · External reference
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
10.1016/s0894-7317(89)80014-8 · 1989 · External reference
Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes
10.1371/journal.pone.0068697 · 2013 · External reference
Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury
10.1093/cvr/cvu105 · 2014 · External reference
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction
10.1161/circulationaha.110.011031 · 2011 · External reference
Signalling pathways for cardiac hypertrophy
10.1016/s0898-6568(98)00036-9 · 1998 · External reference
The progression of hypertensive heart disease
10.1161/circulationaha.108.845792 · 2011 · External reference
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms
10.1152/ajpheart.00002.2009 · 2009 · External reference
Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes
10.1161/01.hyp.0000176236.55322.18 · 2005 · External reference
Interferon-gamma ablation exacerbates myocardial hypertrophy in diastolic heart failure
10.1152/ajpheart.00298.2012 · 2012 · External reference
Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy
10.1161/01.cir.83.1.181 · 1991 · External reference
Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction
10.1161/circulationaha.114.009625 · 2015 · External reference
CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF
10.1016/j.jcmg.2014.04.022 · 2014 · External reference
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes
10.1161/circulationaha.111.080770 · 2012 · External reference
Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction
10.1007/s12265-013-9472-1 · 2013 · External reference
Heart failure with preserved ejection fraction: current understandings and challenges
10.1007/s11886-014-0501-8 · 2014 · External reference
10.1093/eurheartj/ehs104
10.1093/eurheartj/ehs104 · 2012 · External reference
Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay
10.1373/clinchem.2009.129411 · 2009 · External reference
Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models
10.1161/circulationaha.112.115089 · 2012 · External reference
Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model
10.1681/asn.2014020210 · 2015 · External reference
Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways
10.1161/01.cir.0000135599.33787.ca · 2004 · External reference
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy
10.1016/s0735-1097(02)02382-3 · 2002 · External reference
Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation
10.1074/jbc.273.9.4883 · 1998 · External reference
Pathological ventricular remodeling: mechanisms: part 1 of 2
10.1161/circulationaha.113.001878 · 2013 · External reference
Myocardial hypertrophy and its role in heart failure with preserved ejection fraction
10.1152/japplphysiol.00374.2015 · 2015 · External reference
Tackling heart failure in the twenty-first century
10.1038/nature06798 · 2008 · External reference
Regulation of cardiac hypertrophy by intracellular signalling pathways
10.1038/nrm1983 · 2006 · External reference
The pathophysiology of heart failure with preserved ejection fraction: from molecular mechanisms to exercise haemodynamics
10.1016/j.ijcard.2011.06.113 · 2012 · External reference
Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
10.1084/jem.20121878 · 2015 · External reference
Long-term antihypertensive treatment fails to improve E/e′ despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy
10.1161/hypertensionaha.113.01360 · 2014 · External reference
Follistatin-like 1: a potential mediator of inflammation in obesity
10.1155/2013/752519 · 2013 · External reference
Follistatin-like protein 1 and its role in inflammation and inflammatory diseases
10.1007/s12026-014-8526-z · 2014 · External reference
Inflammation in HFpEF: key or circumstantial?
10.1016/j.ijcard.2015.04.110 · 2015 · External reference
Heart failure: pentraxin 3—a marker of diastolic dysfunction and HF?
10.1038/nrcardio.2011.50 · 2011 · External reference
